company background image
4130 logo

Genovate Biotechnology TPEX:4130 Stock Report

Last Price

NT$24.10

Market Cap

NT$2.6b

7D

-2.6%

1Y

-15.7%

Updated

13 Jul, 2024

Data

Company Financials

Genovate Biotechnology Co., Ltd.

TPEX:4130 Stock Report

Market Cap: NT$2.6b

Genovate Biotechnology Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Genovate Biotechnology
Historical stock prices
Current Share PriceNT$24.10
52 Week HighNT$29.80
52 Week LowNT$23.60
Beta0.099
11 Month Change-1.03%
3 Month Change-3.41%
1 Year Change-15.73%
33 Year Change-2.26%
5 Year Change-11.09%
Change since IPO25.37%

Recent News & Updates

Recent updates

Reflecting on Genovate Biotechnology's (GTSM:4130) Share Price Returns Over The Last Five Years

Mar 09
Reflecting on Genovate Biotechnology's (GTSM:4130) Share Price Returns Over The Last Five Years

Does It Make Sense To Buy Genovate Biotechnology Co., Ltd. (GTSM:4130) For Its Yield?

Feb 10
Does It Make Sense To Buy Genovate Biotechnology Co., Ltd. (GTSM:4130) For Its Yield?

Genovate Biotechnology Co., Ltd.'s (GTSM:4130) Dismal Stock Performance Reflects Weak Fundamentals

Jan 04
Genovate Biotechnology Co., Ltd.'s (GTSM:4130) Dismal Stock Performance Reflects Weak Fundamentals

How Much Did Genovate Biotechnology's(GTSM:4130) Shareholders Earn From Share Price Movements Over The Last Five Years?

Dec 08
How Much Did Genovate Biotechnology's(GTSM:4130) Shareholders Earn From Share Price Movements Over The Last Five Years?

Shareholder Returns

4130TW PharmaceuticalsTW Market
7D-2.6%-3.6%1.3%
1Y-15.7%15.2%36.7%

Return vs Industry: 4130 underperformed the TW Pharmaceuticals industry which returned 15.2% over the past year.

Return vs Market: 4130 underperformed the TW Market which returned 36.7% over the past year.

Price Volatility

Is 4130's price volatile compared to industry and market?
4130 volatility
4130 Average Weekly Movement1.9%
Pharmaceuticals Industry Average Movement4.5%
Market Average Movement4.8%
10% most volatile stocks in TW Market8.6%
10% least volatile stocks in TW Market2.3%

Stable Share Price: 4130 has not had significant price volatility in the past 3 months.

Volatility Over Time: 4130's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1982194Chia-Chen Chuwww.genovate-bio.com

Genovate Biotechnology Co., Ltd. operates as a specialty pharmaceutical company in Taiwan. It offers central nervous system drugs, cardiovascular drugs, musculoskeletal drugs, immune preparation drugs, anti-infective agents, anticancer drugs, anti-viral drugs, respiratory drugs, genitourinary drugs, and gastrointestinal drugs. The company manufactures active pharmaceutical ingredients, intermediates, controlled release medicine, and cosmetic products.

Genovate Biotechnology Co., Ltd. Fundamentals Summary

How do Genovate Biotechnology's earnings and revenue compare to its market cap?
4130 fundamental statistics
Market capNT$2.64b
Earnings (TTM)NT$32.92m
Revenue (TTM)NT$536.30m

80.1x

P/E Ratio

4.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4130 income statement (TTM)
RevenueNT$536.30m
Cost of RevenueNT$320.80m
Gross ProfitNT$215.50m
Other ExpensesNT$182.58m
EarningsNT$32.92m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.30
Gross Margin40.18%
Net Profit Margin6.14%
Debt/Equity Ratio0%

How did 4130 perform over the long term?

See historical performance and comparison

Dividends

0.6%

Current Dividend Yield

50%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.